Caudatin inhibits the tumor progression by targeting the cytochrome c/caspase and TNFAIP1/NF-κB signaling pathways, as well as reducing the clonogenicity and viability of uterine cancerous cells (Tan et al., 2016). Here, CYCS is linked to neoplasm.